Ministry of Health (ministry of health), through the National Agency for Pharmacy and Drugs, with reference to the statement issued by the U.S. Food and Drug Administration ( U.S. Food and Drug Administration) relates to the marketing in the United States of eye drops that are not approved by this regulatory agency.
Eye drops sold illegally are used to treat conjunctivitis, cataracts, glaucoma and other conditions. The labels on some of these eye products indicate the presence of silver, which may be characterized as silver sulfate or silver.
The National Agency of Pharmacy and Drugs advises to avoid purchasing medicines over the Internet as products purchased this way may be counterfeit or adulterated, which may seriously affect your health. Do not self-medicate.
Water droplets pose greater risk of damage
The FDA mentioned in its publication that it has issued warning letters to eight companies for producing or selling unapproved ophthalmic drug products in violation of federal law, according to the Minsa Pharmacy and Drug Administration.
The FDA said in a statement that these unapproved and illegally marketed ophthalmic drugs pose a greater risk of harm to users because the drugs used on the eyes evade some of the body’s natural defenses.
The agency issued warning letters to the following companies: Boiron Inc., CVS Health, DR Vitamin Solutions, Natural Ophthalmic, Inc., Oclumed LLC, Similasan AG/Similasan USA Walgreens Boots Alliance Inc., TRP Inc.
Consequences of using drops
Long-term use of silver-containing medications can cause certain areas of the skin and other body tissues, including eye tissue, to permanently turn gray or bluish-gray, called “argyria.”
Additionally, unapproved drugs that claim to cure, treat, or prevent serious illnesses may cause consumers to delay or stop treatments that are found to be safe and effective through the regulatory agency review process.